These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28351888)

  • 21. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice.
    Stukas S; Freeman L; Lee M; Wilkinson A; Ossoli A; Vaisman B; Demosky S; Chan J; Hirsch-Reinshagen V; Remaley AT; Wellington CL
    J Lipid Res; 2014 Aug; 55(8):1721-9. PubMed ID: 24950691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI.
    de Beer MC; Durbin DM; Cai L; Mirocha N; Jonas A; Webb NR; de Beer FC; van Der Westhuyzen DR
    J Biol Chem; 2001 May; 276(19):15832-9. PubMed ID: 11279034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea.
    Flores R; Jin X; Chang J; Zhang C; Cogan DG; Schaefer EJ; Kruth HS
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
    Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
    J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase.
    Mowri HO; Patsch JR; Ritsch A; Föger B; Brown S; Patsch W
    J Lipid Res; 1994 Feb; 35(2):291-300. PubMed ID: 8169533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
    Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
    J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HDL-Mediated Lipid Influx to Endothelial Cells Contributes to Regulating Intercellular Adhesion Molecule (ICAM)-1 Expression and eNOS Phosphorylation.
    Muñoz-Vega M; Massó F; Páez A; Vargas-Alarcón G; Coral-Vázquez R; Mas-Oliva J; Carreón-Torres E; Pérez-Méndez Ó
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice.
    Manzini S; Pinna C; Busnelli M; Cinquanta P; Rigamonti E; Ganzetti GS; Dellera F; Sala A; Calabresi L; Franceschini G; Parolini C; Chiesa G
    Vascul Pharmacol; 2015 Nov; 74():114-121. PubMed ID: 26254103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
    Sparks DL; Frank PG; Neville TA
    Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
    Ohta T; Ikeda Y; Hattori S; Matsuda I
    Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. eNOS activation by HDL is impaired in genetic CETP deficiency.
    Gomaraschi M; Ossoli A; Pozzi S; Nilsson P; Cefalù AB; Averna M; Kuivenhoven JA; Hovingh GK; Veglia F; Franceschini G; Calabresi L
    PLoS One; 2014; 9(5):e95925. PubMed ID: 24830642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency.
    Chroni A; Duka A; Kan HY; Liu T; Zannis VI
    Biochemistry; 2005 Nov; 44(43):14353-66. PubMed ID: 16245952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LCAT-dependent conversion of prebeta1-HDL into alpha-migrating HDL is severely delayed in hemodialysis patients.
    Miida T; Miyazaki O; Hanyu O; Nakamura Y; Hirayama S; Narita I; Gejyo F; Ei I; Tasaki K; Kohda Y; Ohta T; Yata S; Fukamachi I; Okada M
    J Am Soc Nephrol; 2003 Mar; 14(3):732-8. PubMed ID: 12595510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
    Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.